How much did Biolight Life Sciences achieve in EBIT for the current year?
In the current year, Biolight Life Sciences has achieved an EBIT of -10.65 M ILS.
Biolight Life Sciences EBIT 2025
Biolight Life Sciences EBIT
-10.65 M ILS
Ticker
BOLT.TA
ISIN
IL0010952237
In 2025, Biolight Life Sciences's EBIT was -10.65 M ILS, a 3.19% increase from the -10.32 M ILS EBIT recorded in the previous year.
The Biolight Life Sciences EBIT history
| YEAR | EBIT (undefined ILS) |
|---|---|
| 2023 | -10.65 |
| 2022 | -10.32 |
| 2021 | -10.6 |
| 2020 | -11.33 |
| 2019 | -14.02 |
| 2018 | 53.95 |
| 2017 | -26.88 |
| 2016 | -30.4 |
| 2015 | -26.56 |
| 2014 | -33.61 |
| 2013 | -28.44 |
| 2012 | -9.52 |
| 2011 | -12.4 |
| 2010 | -21.81 |
| 2009 | -24.96 |
| 2008 | -19.67 |
| 2007 | -29.11 |
| 2006 | -24.02 |
| 2005 | -2.03 |
Biolight Life Sciences Revenue, EBIT, Net Income IL0010952237 ·
3 years
5 years
10 years
25 Years
Max
Revenue
EBIT
Net Income
Details
Revenue, EBIT and Profit
ⓘUnderstanding Revenue, EBIT, and Income
Gain insights into Biolight Life Sciences, a comprehensive overview of its financial performance can be obtained by analyzing the Revenue, EBIT, and Income chart. Revenue represents the total income generated by Biolight Life Sciences from its primary operations, showcasing the company’s ability to attract and retain clients. EBIT, or Earnings Before Interest and Taxes, indicates the company’s operational profitability, free from the influence of tax and interest expenses. The Income section reflects Biolight Life Sciences’s net earnings, an ultimate measure of its financial health and profitability.
Yearly Analysis and Comparisons
Observe the yearly bars to understand the annual performance and growth of Biolight Life Sciences. Compare the Revenue, EBIT, and Income to evaluate the company’s efficiency and profitability. A higher EBIT compared to the previous year suggests an improvement in operational efficiency. Likewise, an increase in Income indicates enhanced overall profitability. Analyzing the year-to-year comparison assists investors in understanding the company’s growth trajectory and operational efficiency.
Utilizing Expectations for Investment
The expected values for the forthcoming years offer investors a glimpse into Biolight Life Sciences’s anticipated financial performance. Analyzing these projections alongside historical data aids in making informed investment decisions. Investors can gauge the potential risks and returns, aligning their investment strategies accordingly to optimize profitability and mitigate risks.
Investment Insights
Leveraging the comparison between Revenue and EBIT helps in assessing Biolight Life Sciences’s operational efficiency, while the Revenue and Income comparison reveals the net profitability after accounting for all expenses. Investors can derive valuable insights by meticulously analyzing these financial parameters, laying the foundation for strategic investment decisions aimed at capitalizing on Biolight Life Sciences’s growth potential.
Biolight Life Sciences Revenue, EBIT and net profit per share
| Date | Biolight Life Sciences Revenue | Biolight Life Sciences EBIT | Biolight Life Sciences Net Income |
|---|---|---|---|
| 2023 | 118,000 undefined | -10.65 M undefined | -26.02 M undefined |
| 2022 | 63,000 undefined | -10.32 M undefined | -7.85 M undefined |
| 2021 | 3,000 undefined | -10.6 M undefined | 382,000 undefined |
| 2020 | 31,000 undefined | -11.33 M undefined | -13.38 M undefined |
| 2019 | 297,000 undefined | -14.02 M undefined | -12.59 M undefined |
| 2018 | 3.69 M undefined | 53.95 M undefined | 65.39 M undefined |
| 2017 | 1.21 M undefined | -26.88 M undefined | -17.26 M undefined |
| 2016 | 2.11 M undefined | -30.4 M undefined | -21.82 M undefined |
| 2015 | 1.39 M undefined | -26.56 M undefined | -19.26 M undefined |
| 2014 | 941,000 undefined | -33.61 M undefined | -23.1 M undefined |
| 2013 | 80,000 undefined | -28.44 M undefined | -18.84 M undefined |
| 2012 | 790,000 undefined | -9.52 M undefined | -12.73 M undefined |
| 2011 | 50,000 undefined | -12.4 M undefined | -1.81 M undefined |
| 2010 | 0 undefined | -21.81 M undefined | -19.51 M undefined |
| 2009 | 0 undefined | -24.96 M undefined | -25.43 M undefined |
| 2008 | 0 undefined | -19.67 M undefined | -18.34 M undefined |
| 2007 | 0 undefined | -29.11 M undefined | -32.61 M undefined |
| 2006 | 0 undefined | -24.02 M undefined | -27.5 M undefined |
| 2005 | 0 undefined | -2.03 M undefined | -1.99 M undefined |
| Revenue | EBIT | Net Income | |
|---|---|---|---|
| 2005 | 0 ILS | -2.03 M ILS | -1.99 M ILS |
| 2006 | 0 ILS | -24.02 M ILS | -27.5 M ILS |
| 2007 | 0 ILS | -29.11 M ILS | -32.61 M ILS |
| 2008 | 0 ILS | -19.67 M ILS | -18.34 M ILS |
| 2009 | 0 ILS | -24.96 M ILS | -25.43 M ILS |
| 2010 | 0 ILS | -21.81 M ILS | -19.51 M ILS |
| 2011 | 50,000 ILS | -12.4 M ILS | -1.81 M ILS |
| 2012 | 790,000 ILS | -9.52 M ILS | -12.73 M ILS |
| 2013 | 80,000 ILS | -28.44 M ILS | -18.84 M ILS |
| 2014 | 941,000 ILS | -33.61 M ILS | -23.1 M ILS |
| 2015 | 1.39 M ILS | -26.56 M ILS | -19.26 M ILS |
| 2016 | 2.11 M ILS | -30.4 M ILS | -21.82 M ILS |
| 2017 | 1.21 M ILS | -26.88 M ILS | -17.26 M ILS |
| 2018 | 3.69 M ILS | 53.95 M ILS | 65.39 M ILS |
| 2019 | 297,000 ILS | -14.02 M ILS | -12.59 M ILS |
| 2020 | 31,000 ILS | -11.33 M ILS | -13.38 M ILS |
| 2021 | 3,000 ILS | -10.6 M ILS | 382,000 ILS |
| 2022 | 63,000 ILS | -10.32 M ILS | -7.85 M ILS |
| 2023 | 118,000 ILS | -10.65 M ILS | -26.02 M ILS |
Biolight Life Sciences stock margins IL0010952237 ·
The Biolight Life Sciences margin analysis displays the gross margin, EBIT margin, as well as the profit margin of Biolight Life Sciences. The EBIT margin (EBIT/sales) indicates the percentage of sales that remains as operating profit. The profit margin shows the percentage of sales that remains for Biolight Life Sciences.
3 years
5 years
10 years
25 Years
Max
Gross margin
EBIT margin
Profit margin
Details
Margin
ⓘUnderstanding Gross Margin
The gross margin, expressed as a percentage, delineates the gross profit made from the Biolight Life Sciences's sales revenue. A higher gross margin percentage indicates that the Biolight Life Sciences retains more revenue after accounting for the costs of goods sold. Investors use this metric to gauge financial health and operational efficiency, as well as to compare it with competitors and industry averages.
EBIT Margin Analysis
EBIT margin represents the Biolight Life Sciences's earnings before interest and taxes. Analyzing the EBIT margin over different years provides insights into the operational profitability and efficiency, excluding the effects of financial leverage and tax structure. A growing EBIT margin over the years signifies improving operational performance.
Revenue Margin Insights
The revenue margin demonstrates the Biolight Life Sciences's total revenue generated. When comparing the revenue margin year over year, investors can gauge the Biolight Life Sciences's growth and market expansion. It is essential to compare the revenue margin with the gross and EBIT margins to understand the cost and profit structures better.
Interpreting Expectations
The expected values for gross, EBIT, and revenue margins provide future financial outlook of the Biolight Life Sciences. Investors should compare these expectations with historical data to understand potential growth and risk factors. It is crucial to consider the underlying assumptions and methodologies used in projecting these expected values to make informed investment decisions.
Comparative Analysis
Comparing the gross, EBIT, and revenue margins, both yearly and over multiple years, enables investors to perform a comprehensive analysis of the Biolight Life Sciences's financial health and growth prospects. Evaluating the trends and patterns in these margins helps in identifying strengths, weaknesses, and potential investment opportunities.
Biolight Life Sciences Margin History
| Biolight Life Sciences Gross margin | Biolight Life Sciences Profit margin | Biolight Life Sciences EBIT margin | Biolight Life Sciences Profit margin |
|---|---|---|---|
| 2023 | 100 % | -9,026.27 % | -22,050.85 % |
| 2022 | 100 % | -16,384.13 % | -12,455.56 % |
| 2021 | 100 % | -353,433.33 % | 12,733.33 % |
| 2020 | 100 % | -36,541.94 % | -43,167.74 % |
| 2019 | 69.7 % | -4,719.87 % | -4,239.39 % |
| 2018 | 20.61 % | 1,463.33 % | 1,773.39 % |
| 2017 | 37.22 % | -2,223.16 % | -1,427.63 % |
| 2016 | 52.82 % | -1,440.17 % | -1,033.82 % |
| 2015 | 47.23 % | -1,909.2 % | -1,384.54 % |
| 2014 | 42.83 % | -3,571.31 % | -2,455.05 % |
| 2013 | 75 % | -35,550 % | -23,550 % |
| 2012 | 100 % | -1,205.06 % | -1,611.39 % |
| 2011 | 100 % | -24,800 % | -3,620 % |
| 2010 | 100 % | 0 % | 0 % |
| 2009 | 100 % | 0 % | 0 % |
| 2008 | 100 % | 0 % | 0 % |
| 2007 | 100 % | 0 % | 0 % |
| 2006 | 100 % | 0 % | 0 % |
| 2005 | 100 % | 0 % | 0 % |
| Gross margin | EBIT margin | Profit margin | |
|---|---|---|---|
| 2005 | 100 % | 0 % | 0 % |
| 2006 | 100 % | 0 % | 0 % |
| 2007 | 100 % | 0 % | 0 % |
| 2008 | 100 % | 0 % | 0 % |
| 2009 | 100 % | 0 % | 0 % |
| 2010 | 100 % | 0 % | 0 % |
| 2011 | 100 % | -24,800 % | -3,620 % |
| 2012 | 100 % | -1,205.06 % | -1,611.39 % |
| 2013 | 75 % | -35,550 % | -23,550 % |
| 2014 | 42.83 % | -3,571.31 % | -2,455.05 % |
| 2015 | 47.23 % | -1,909.2 % | -1,384.54 % |
| 2016 | 52.82 % | -1,440.17 % | -1,033.82 % |
| 2017 | 37.22 % | -2,223.16 % | -1,427.63 % |
| 2018 | 20.61 % | 1,463.33 % | 1,773.39 % |
| 2019 | 69.7 % | -4,719.87 % | -4,239.39 % |
| 2020 | 100 % | -36,541.94 % | -43,167.74 % |
| 2021 | 100 % | -353,433.33 % | 12,733.33 % |
| 2022 | 100 % | -16,384.13 % | -12,455.56 % |
| 2023 | 100 % | -9,026.27 % | -22,050.85 % |
Biolight Life Sciences Aktienanalyse
What does Biolight Life Sciences do?
Biolight Life Sciences Ltd is a global company specializing in the development, production, and marketing of medical devices and products. It was founded in China in 1993 and has since relocated its headquarters to Israel. Biolight has evolved from a small company to a leading provider of medical devices and products that help improve patient treatment and optimize healthcare. The company's business model is based on selling medical devices and products used in diagnosis, monitoring, and treatment of patients. It continually strives to improve its products through research and development to enhance healthcare worldwide. Biolight believes that cooperative technologies and services can create synergistic value that benefits patients. Its various divisions include monitoring and diagnostic devices, cardiology products, and emergency medicine products. Biolight offers a wide range of products to ensure quality healthcare. Its monitoring and diagnostic devices measure various physiological parameters such as blood pressure, heart rate, respiration, oxygen saturation, and temperature. The cardiology products are tailored to the needs of heart patients and include EKG devices, long-term EKG systems, and Holter devices. The emergency medicine products treat life-threatening conditions such as heart attacks, strokes, and respiratory distress, thereby saving lives. To ensure a high-quality healthcare system, it is essential for medical devices and products to meet the highest standards. Biolight is aware of this and is committed to offering products that comply with the strictest international quality standards such as ISO 13485, CE, and FDA. Biolight has a broad global presence with branches and subsidiaries in numerous countries such as the USA, China, India, Germany, Spain, and France. This global presence enables the company to understand and meet the needs of patients and medical personnel in different parts of the world. Biolight also collaborates with partners and customers to further improve its products and services and meet market demands. Overall, Biolight has made a sustainable contribution to improving healthcare. Through its continuous research and development, products and services, and global presence, the company has established itself as a key player in the medical technology industry. By working with partners and customers, Biolight can contribute to ensuring that patients worldwide have access to the best healthcare. Biolight Life Sciences ist eines der beliebtesten Unternehmen auf Eulerpool.com.EBIT Details
Analyzing Biolight Life Sciences's EBIT
Biolight Life Sciences's Earnings Before Interest and Taxes (EBIT) represents the company's operating profit. It is calculated by deducting all operating expenses, including the cost of goods sold (COGS) and operating expenses, from the total revenue, but before accounting for interest and taxes. It provides insights into the company’s operational profitability, excluding the impacts of financing and tax structures.
Year-to-Year Comparison
A yearly comparison of Biolight Life Sciences's EBIT can reveal trends in the company’s operational efficiency and profitability. An increase in EBIT over the years can indicate enhanced operational efficiency or growth in revenue, while a decrease might raise concerns about increased operating costs or declining sales.
Impact on Investments
Biolight Life Sciences's EBIT is a significant metric for investors. A positive EBIT suggests that the company is generating enough revenue to cover its operating expenses, an essential aspect for assessing the company’s financial health and stability. Investors closely monitor EBIT to gauge the company’s profitability and potential for future growth.
Interpreting EBIT Fluctuations
Fluctuations in Biolight Life Sciences’s EBIT can be due to variations in revenue, operating expenses, or both. An increasing EBIT indicates improved operational performance or increased sales, while a declining EBIT can signal rising operational costs or reduced revenue, prompting a need for strategic adjustments.
Frequently Asked Questions about Biolight Life Sciences stock
What is EBIT?
EBIT stands for Earnings Before Interest and Taxes and refers to the profit before interest and taxes of a company Biolight Life Sciences.
How has the EBIT of Biolight Life Sciences developed in recent years?
The EBIT of Biolight Life Sciences has increased by 3.187% increased compared to the previous year.
What does EBIT mean for investors?
EBIT provides investors with insights into a company's profitability as it reflects the profit before interest expenses and taxes.
Why is EBIT an important indicator for investors?
Since EBIT provides a more direct insight into a company's profit than net income, it is an important indicator for investors to assess the profitability of a company.
Why do EBIT values fluctuate?
EBIT values can fluctuate as they are influenced by various factors, such as revenue, costs, and tax effects.
What role does tax burden play in EBIT?
Tax burdens have a direct impact on a company's EBIT, as they are deducted from the profit.
How is EBIT presented in the balance sheet of the company Biolight Life Sciences?
The EBIT of Biolight Life Sciences is listed in the income statement.
Can EBIT be used as a single indicator for evaluating a company?
EBIT is an important indicator for evaluating a company, but additional financial ratios should also be considered to get a comprehensive picture.
Why is EBIT not equal to net profit?
The net profit of a company includes taxes and interest, while EBIT represents the profit before interest and taxes.
How much dividend does Biolight Life Sciences pay?
Over the past 12 months, Biolight Life Sciences paid a dividend of . This corresponds to a dividend yield of about . For the coming 12 months, Biolight Life Sciences is expected to pay a dividend of 0 ILS.
What is the dividend yield of Biolight Life Sciences?
The current dividend yield of Biolight Life Sciences is .
When does Biolight Life Sciences pay dividends?
Biolight Life Sciences pays a quarterly dividend. This is distributed in the months of .
How secure is the dividend of Biolight Life Sciences?
Biolight Life Sciences paid dividends every year for the past 0 years.
What is the dividend of Biolight Life Sciences?
For the upcoming 12 months, dividends amounting to 0 ILS are expected. This corresponds to a dividend yield of 0 %.
In which sector is Biolight Life Sciences located?
Biolight Life Sciences is assigned to the 'Health' sector.
Wann musste ich die Aktien von Biolight Life Sciences kaufen, um die vorherige Dividende zu erhalten?
To receive the latest dividend of Biolight Life Sciences from 2/2/2025 amounting to 0 ILS, you needed to have the stock in your portfolio before the ex-date on 2/2/2025.
When did Biolight Life Sciences pay the last dividend?
The last dividend was paid out on 2/2/2025.
What was the dividend of Biolight Life Sciences in the year 2024?
In the year 2024, Biolight Life Sciences distributed 0 ILS as dividends.
In which currency does Biolight Life Sciences pay out the dividend?
The dividends of Biolight Life Sciences are distributed in ILS.
Stock savings plans offer an attractive way for investors to build wealth over the long term. One of the main advantages is the so-called cost-average effect: by regularly investing a fixed amount in stocks or stock funds, you automatically buy more shares when prices are low, and fewer when they are high. This can lead to a more favorable average price per share over time. In addition, stock savings plans allow small investors access to expensive stocks, as they can participate with small amounts. Regular investment also promotes a disciplined investment strategy and helps to avoid emotional decisions, such as impulsive buying or selling. Furthermore, investors benefit from the potential appreciation of the stocks as well as from dividend distributions, which can be reinvested, enhancing the compounding effect and thus the growth of the invested capital.
Andere Kennzahlen von Biolight Life Sciences
Our stock analysis for Biolight Life Sciences Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Biolight Life Sciences Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.
- Biolight Life Sciences Revenue
- Biolight Life Sciences Net Income
- Biolight Life Sciences P/E
- Biolight Life Sciences P/S
- Biolight Life Sciences EBIT
- Biolight Life Sciences Dividend
- Biolight Life Sciences Stocks
- Biolight Life Sciences Market capitalization
- Biolight Life Sciences Debt
- Biolight Life Sciences Liabilities
- Biolight Life Sciences Equity
- Biolight Life Sciences AAQS
- Biolight Life Sciences Employees
- Biolight Life Sciences ROE
- Biolight Life Sciences ROA
- Biolight Life Sciences ROCE
